- Trials with a EudraCT protocol (29)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
29 result(s) found for: Respiratory acidosis.
Displaying page 1 of 2.
| EudraCT Number: 2010-023129-39 | Sponsor Protocol Number: MP4OX-10-TRA-205 | Start Date*: 2011-03-22 | ||||||||||||||||
| Sponsor Name:Sangart, Inc. | ||||||||||||||||||
| Full Title: Estudio multicéntrico, aleatorizado, en doble ciego y controlado, para evaluar la seguridad y la eficacia del tratamiento con MP4OX, añadido al tratamiento habitual, en pacientes con traumatismo se... | ||||||||||||||||||
| Medical condition: Pacientes con traumatismo severo y acidosis láctica por shock hemorrágico.//Severely injured trauma patients with lactic acidosis due to hemorrhagic shock. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Ongoing) AT (Completed) DE (Completed) GB (Completed) NO (Completed) IT (Ongoing) BE (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2021-006427-18 | Sponsor Protocol Number: 2021.143 | Start Date*: 2022-08-26 |
| Sponsor Name:Anna Coquard Rafales | ||
| Full Title: M-POC-O2: high flow nasal cannula oxygen versus conventional oxygen therapy in exacerbated chronic obstructive pulmonary disease (COPD) patients without respiratory acidosis. Pilot Study. | ||
| Medical condition: Patients older than 35 years old with COPD diagnosis (chronic obstructive pulmonary disease) by spirometry, presenting acute exacerbation without respiratory acidosis. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004384-29 | Sponsor Protocol Number: Levosepsis1 | Start Date*: 2005-05-23 |
| Sponsor Name:Dr GED DEMPSEY, University Hospital Aintree | ||
| Full Title: Double blind randomised controlled trial of Levosimendan versus Dopexamine in septic shock | ||
| Medical condition: Septic Shock | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002498-80 | Sponsor Protocol Number: 06062019 | Start Date*: 2019-09-24 | |||||||||||
| Sponsor Name:Mikkel Brabrand | |||||||||||||
| Full Title: Will titrated oxygen flow to a peripheral oxygen saturation of 88-92% compared with oxygen flow to a saturation >94% reduce mortality in Chronic Obstructive Pulmonary Disease patients with acute ex... | |||||||||||||
| Medical condition: Acute COPD Exacerbation | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-001726-99 | Sponsor Protocol Number: P17/15 | Start Date*: 2021-07-12 |
| Sponsor Name:Centre Hospitalier de Versailles | ||
| Full Title: Comparison of corticosteroids versus placebo on duration of ventilatory support during severe acute exacerbations of COPD patients in the intensive care unit: a multicentre randomized controlled tr... | ||
| Medical condition: Severe acute exacerbations of Chronic Obstructive Pulmonary Disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-000406-51 | Sponsor Protocol Number: EMD20001 | Start Date*: 2004-09-16 |
| Sponsor Name:GlaxoSmithKline | ||
| Full Title: A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment o... | ||
| Medical condition: Suspected or Confirmed Gram-negative Severe Sepsis in Adults | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) ES (Completed) CZ (Completed) LV (Completed) AT (Completed) HU (Completed) DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-005441-38 | Sponsor Protocol Number: F1K-MC-EVDP | Start Date*: 2008-03-07 | |||||||||||
| Sponsor Name:Eli Lilly and Company | |||||||||||||
| Full Title: Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock | |||||||||||||
| Medical condition: Septic shock | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) GB (Completed) NL (Completed) FR (Completed) BE (Completed) IT (Completed) PT (Completed) FI (Completed) CZ (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-001579-22 | Sponsor Protocol Number: OPTINEB | Start Date*: 2017-10-20 | |||||||||||
| Sponsor Name:CHU DE POITIERS | |||||||||||||
| Full Title: Effectiveness of nebulization by high nasal flow during acute respiratory decompensations of chronic respiratory insufficiency. | |||||||||||||
| Medical condition: | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-004704-35 | Sponsor Protocol Number: NL39417.078.12 | Start Date*: 2012-11-22 |
| Sponsor Name: | ||
| Full Title: Thiazide diuretics versus calcium channel blockers for the treatment of tacrolimus-induced hypertension in dermatology patients: a single-center randomized cross-over trial. | ||
| Medical condition: Hypertension, induced by the use of a Calcineurin Inhibitor (CNI) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-000769-13 | Sponsor Protocol Number: AP SEP 02-02 | Start Date*: 2006-06-13 |
| Sponsor Name:AM-Pharma | ||
| Full Title: A double-blind, randomized, placebo-controlled study to investigate the clinical efficacy and safety of two doses of Alkaline Phosphatase administered for three days in patients with severe sepsi... | ||
| Medical condition: Severe sepsis and septic shock | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-003551-22 | Sponsor Protocol Number: 55029 | Start Date*: 2016-12-28 | ||||||||||||||||
| Sponsor Name:Erasmus MC - Sophia Children's Hospital | ||||||||||||||||||
| Full Title: STATIC IV: Efficacy of a loading dose of intravenous salbutamol in patients admitted to a PICU for severe acute asthma | ||||||||||||||||||
| Medical condition: Severe acute (viral) wheeze and severe acute asthma | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2016-004198-41 | Sponsor Protocol Number: UCDCRC/16/003 | Start Date*: 2017-01-27 | |||||||||||
| Sponsor Name:University College Dublin | |||||||||||||
| Full Title: PROPHYLACTIC OROPHARYNGEAL SURFACTANT FOR PRETERM INFANTS: A RANDOMISED TRIAL (THE POPART TRIAL) | |||||||||||||
| Medical condition: Preterm Infants at risk of respiratory distress syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: IE (Completed) BE (Completed) SE (Completed) CZ (Completed) PT (Completed) NO (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-002996-27 | Sponsor Protocol Number: 13CC34 | Start Date*: 2015-02-02 |
| Sponsor Name:Great Ormond Street Hospital For Children NHS Foundation Trust | ||
| Full Title: Optimising effectiveness and minimising toxicity of intravenous salbutamol in children with acute asthma | ||
| Medical condition: The mainstay of asthma treatment worldwide are β2-agonists and steroids. Current management of childhood acute asthma is based on British Thoracic Society guidelines, which recommend IVS as second ... | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2023-000010-18 | Sponsor Protocol Number: WATERLAND | Start Date*: 2023-03-23 | |||||||||||
| Sponsor Name:Enrique de Madaria | |||||||||||||
| Full Title: Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial | |||||||||||||
| Medical condition: Acute pancreatitis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-001726-22 | Sponsor Protocol Number: COLIGROW | Start Date*: 2022-12-12 | |||||||||||
| Sponsor Name:Dr. Ignacio Herraiz García | |||||||||||||
| Full Title: COok's ballon versus dinoprostone for Labor Induction of term pregnancies with fetal GROWth restriction (COLIGROW study). | |||||||||||||
| Medical condition: Induction of term pregnancies with fetal growth restriction. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-005537-35 | Sponsor Protocol Number: E5564-G000-301 | Start Date*: 2006-08-30 | |||||||||||
| Sponsor Name:Eisai Limited | |||||||||||||
| Full Title: ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients with Severe Sepsis | |||||||||||||
| Medical condition: Severe Sepsis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) NL (Completed) AT (Completed) CZ (Completed) ES (Completed) DE (Completed) PT (Prematurely Ended) IT (Prematurely Ended) GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-014344-11 | Sponsor Protocol Number: prot-001-2009 | Start Date*: 2010-06-02 | |||||||||||
| Sponsor Name:Imperial College London | |||||||||||||
| Full Title: Neuroprotective effects of hypothermia combined with inhaled xenon following perinatal asphyxia - the TOBY Xe trial | |||||||||||||
| Medical condition: Neonatal asphyxial encephalopathy | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-000770-29 | Sponsor Protocol Number: Ireland-RctV8 | Start Date*: 2018-06-18 | ||||||||||||||||
| Sponsor Name:The Rotunda Hospital | ||||||||||||||||||
| Full Title: Investigating the role of early low-dose aspirin in diabetes: A phase III multicentre double-blinded placebo-controlled randomised trial of low-dose aspirin initiated in the first trimester of diab... | ||||||||||||||||||
| Medical condition: Pregestational type I or type II diabetes | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: IE (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2014-001826-13 | Sponsor Protocol Number: 200721 | Start Date*: 2015-02-16 | |||||||||||
| Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
| Full Title: Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor | |||||||||||||
| Medical condition: preterm labor | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
| Trial protocol: BE (Completed) GB (Completed) SE (Completed) ES (Completed) DE (Completed) IT (Prematurely Ended) FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-016042-57 | Sponsor Protocol Number: JCFG-2010-SSH3% | Start Date*: 2011-10-05 | |||||||||||
| Sponsor Name:Jose Carlos Flores González | |||||||||||||
| Full Title: ENSAYO CLÍNICO ALEATORIZADO, DOBLE CIEGO, CONTROLADO Y PARALELO PARA COMPARAR LA EFICACIA DE LA NEBULIZACIÓN DE SUERO SALINO HIPERTÓNICO AL 3% CON ADRENALINA FRENTE A NEBULIZACIÓN DE SUERO SALINO ... | |||||||||||||
| Medical condition: Bronquiolitis aguda moderada que requiere ingreso hospitalario. Se administrará medicación nebulizada de suero salino hipertónico al 3% más adrenalina frente a nebulización de suero salino hipertón... | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.